Reminiscence therapy and life review

Article written and reviewed by Dr Luca Moretti

Reminiscence therapy includes interventions that use the recall, narration and sharing of autobiographical experiences, especially in older people. The term is often used broadly, but the literature distinguishes at least simple reminiscence, life review with a structured approach, and life-review therapy with clinical aims. This distinction is essential because intensity, goals and effect sizes for depression are not identical across the different approaches.

Simple reminiscence can foster communication, identity and social connection through pleasant or meaningful memories. Life review more systematically covers different stages of life, including achievements, losses, transitions and difficulties. Life review therapy adds a more explicit psychotherapeutic aim: helping the person reconsider unresolved experiences, construct more integrated meanings and reduce processes associated with depression. A conversation about memories should therefore not be treated as equivalent to a validated psychotherapeutic protocol.

The evidence is particularly relevant to late life depression. Historical and recent meta analyses show favorable effects on depressive symptoms, with indications that structured life review interventions for people with clinically significant symptoms tend to produce greater benefits than simple reminiscence in nonclinical populations. A 2026 network meta analysis also compared different reminiscence based therapies in older adults without a diagnosis of MCI or dementia, broadening the comparative picture without eliminating uncertainty related to indirect comparisons.

Reminiscence, life review and life-review therapy

Remembering the past is a normal process throughout the life course and is not, in itself, a therapy. Reminiscence may be spontaneous, social or guided by themes and cues such as photographs, music, objects and places. In care settings, it may aim to promote engagement and well being even when no depressive diagnosis is present.

Life review is more systematic. The person is guided through periods, roles and transitions in their history, examining continuity, changes, choices, relationships, losses and achievements. The modern concept also derives from the work of Robert Butler, who described life review as a psychologically relevant process in later life, but contemporary therapeutic protocols were subsequently formalized and experimentally evaluated.

Life-review therapy uses autobiographical review for a clinical purpose. In addition to evoking memories, it addresses rigid interpretations, regret, guilt, unresolved conflicts and difficulty constructing a coherent narrative of one's life course. Some protocols integrate cognitive, narrative or problem solving elements. The category is therefore heterogeneous, and results from a single manual should not automatically be attributed to all forms of reminiscence.

A further distinction concerns interventions for dementia. Reminiscence therapy has also been studied in neurocognitive disorders, often with goals related to communication, quality of life, mood or relationships with caregivers. This literature is not interchangeable with studies of life review therapy for depression in older adults without cognitive impairment. Diagnoses, outcomes and the capacities required by treatment differ.

Terms such as narrative therapy and dignity therapy may also share autobiographical elements, but they are conceptually distinct interventions. Network meta analyses may group them as reminiscence based therapies for comparative purposes; clinically, however, it remains necessary to specify which protocol is actually being delivered.

The terminological distinction also has consequences for evaluating efficacy. Studies that include healthy participants engaged in social reminiscence activities answer a different question from trials enrolling older adults with depression and applying a manualized life review therapy. Indiscriminately pooling these studies may dilute or inflate estimates and makes it necessary to examine the population, comparator and intervention content carefully before applying a clinical result.

Psychological rationale and possible mechanisms

The rationale for life review does not require assuming a single neurobiological mechanism. Effects may derive from multiple processes: greater autobiographical coherence, reappraisal of events, recovery of experiences of efficacy, processing of losses, improved social connection and reduction of a memory pattern selectively dominated by failures. Available evidence supports clinical outcomes more directly than it supports any specific biological mechanism.

In depression, access to autobiographical memory may be influenced by mood congruent biases and rumination. A structured intervention can help reconstruct a broader picture of one's history, including resources, exceptions and contexts that depressive thinking tends to overlook. This does not mean replacing negative memories with positive ones or denying traumatic experiences.

Review may promote integration when it allows painful events to be placed within a narrative that acknowledges both loss and continuity. In some people, however, recalling the past may temporarily increase sadness, guilt or trauma related symptoms. The presence of a trained professional allows the pace to be adjusted, a destabilizing exploration to be stopped, and therapeutic processing to be distinguished from repetitive rumination.

The group format adds possible interpersonal mechanisms: sharing, normalization, mutual recognition and reduction of isolation. These factors may have value independently of autobiographical content. Studies therefore need to distinguish the specific effect of reminiscence from the effects of attention, socialization and support received in the treatment group.

In older adults, therapy can also strengthen identity and continuity during phases characterized by retirement, bereavement, illness or changes in role. These themes are common but not universal, and the intervention should avoid stereotypes suggesting that old age is necessarily dominated by loss or loneliness.

Autobiographical work is also influenced by culture. The meaning attributed to family, work, migration, religion, war, gender and generational roles changes how events are narrated and evaluated. The therapist should avoid imposing an individualistic interpretation or a normative sequence of life and allow the person to define which events truly matter. This increases the validity of the reconstruction and reduces the risk of turning life review into a standardized interview devoid of personal meaning.

Clinical assessment and delivery

Before starting an intervention for depression, a comprehensive assessment is necessary. In older adults, depressive symptoms, suicide risk, temporal course, medications, pain, medical illnesses, sensory deficits, sleep, substance use and cognitive status should be considered. Delirium, dementia, bipolar disorder and depression secondary to medical conditions may require different pathways.

Cognitive assessment is particularly important because life review therapy requires the ability to follow an autobiographical structure and reflect on the meaning of events. Cognitive impairment does not exclude every form of reminiscence, but it may require a different protocol, greater support, concrete cues and goals focused more on immediate well being than on complex reprocessing.

Interventions may be individual or group based. Sessions may proceed chronologically or by themes such as family, work, friendships, losses, achievements, values and changes. Photographs, letters, music and objects may facilitate recall, but they are not necessary in every protocol and should be used with respect for privacy and preferences.

The therapist distinguishes productive recall from rumination. If the patient repeatedly returns to the same episode without gaining new perspectives and with progressively increasing hopelessness, it may be necessary to interrupt the cycle and use more structured strategies. The goal is not to maximize the number of memories, but to promote processing and integration that are compatible with clinical stability.

Duration varies according to the protocol. Recent meta analyses suggest that characteristics such as structure, clinical population and duration influence outcomes, but there is no universally optimal duration. The 2026 network meta analysis observed associations between interventions lasting at least eight weeks and greater improvements in life satisfaction; this finding does not demonstrate that eight weeks is a causal threshold valid for every patient.

When photographs, letters or recordings are used, it is also appropriate to assess third-party consent and the sensitivity of the materials. Some memories may involve family events that were not shared with others or information the patient does not wish to disclose in a group. The therapist should provide alternative methods and should not make participation dependent on access to autobiographical objects, which may be unavailable precisely in people with histories of migration, loss or institutionalization.

Evidence on late life depression

Early meta analyses of reminiscence and life review reported reductions in depressive symptoms in older adults, contributing to the development of more structured protocols. The 2012 meta analysis by Pinquart and Forstmeier, which considered several psychosocial outcomes, found benefits but also considerable variability related to intervention type and population.

A pragmatic trial by Korte and colleagues studied life-review therapy in older adults with moderate depressive symptoms and showed a reduction in symptoms compared with usual care, with benefits also observed at follow up. The value of this study also lies in its setting, which was closer to routine practice, although the findings cannot automatically be generalized to severe depression or to people with substantial cognitive impairment.

The updated meta analysis published in 2024 in the Journal of Affective Disorders reexamined life review and reminiscence in late life depression. Overall, it confirmed favorable effects but noted greater uncertainty regarding long term effects. This distinction between post treatment benefit and maintenance is essential to avoid presenting the intervention as proven relapse prevention.

A second 2024 meta analysis, focused on randomized trials of reminiscence for depression and anxiety, found a moderate average improvement in depressive symptoms. Effects tended to be greater for life review therapy in people with high levels of psychological symptoms than for life review in nonclinical samples and simple reminiscence. This reinforces the need to distinguish the different categories of intervention.

In 2026, a network meta analysis of 33 trials and 2,512 older participants without MCI or dementia compared different reminiscence based therapies. Narrative therapy and dignity therapy achieved the most favorable rankings for reducing depressive symptoms, and narrative therapy ranked most favorably for life satisfaction. Rankings from a network meta analysis, however, depend on the network of comparisons and do not automatically demonstrate clinical superiority of one treatment for every patient.

Role in guidelines and relationship with other treatments

Major depression in older adults requires the same diagnostic rigor as at other stages of life, with particular attention to medical comorbidities, polypharmacy, frailty and cognition. CBT, behavioral activation, IPT, pharmacotherapy and other treatments have specific evidence bases. Reminiscence or life review therapy should not be presented as an automatic substitute for these interventions when depression is severe or complex.

In mild or moderate presentations and in patients who prefer an autobiographical approach, life review therapy may be an option or a component of a broader plan when a trained professional is available. The choice should consider the exact type of protocol, because simple social reminiscence is not equivalent to a structured psychotherapy.

Therapy may be combined with antidepressants. Autobiographical recall does not alter pharmacological indications and does not justify unsupervised discontinuation. In older adults, medication decisions require particular attention to comorbidities, interactions, fall risk, hyponatremia and other adverse effects, which should be managed by the prescribing physician.

High suicide risk, psychotic symptoms, mania, catatonia, severe food refusal or rapid functional deterioration require more intensive management. In such situations, reminiscence is not sufficient as a standalone treatment and may be inappropriate as a priority. Unprocessed trauma also requires caution because unstructured recall may reactivate symptoms without providing adequate stabilization tools.

The choice should also consider the clinical goal. A reminiscence program in a residential facility may be appropriate for socialization and well being while still being insufficient treatment for major depression. Conversely, a manualized life review therapy may have a specific antidepressant aim. Explicitly stating the objective prevents a care activity from being presented as a substitute for psychotherapy or psychiatric assessment.

In patients with depression associated with neurological or medical illness, the intervention should be coordinated with the healthcare pathway. Fatigue, pain, hearing impairment and visual difficulties may require shorter sessions, adapted materials or breaks. Autobiographical benefit does not eliminate the need to treat somatic conditions that contribute directly to depressive symptoms or disability.

Safety, limitations and prognosis

Reminiscence is often perceived as harmless, but recalling bereavement, violence, failures or traumatic relationships may produce significant distress. The therapist should obtain consent regarding the depth of exploration, respect the right not to explore a memory further and monitor for worsening mood, dissociation, insomnia or increased suicidal ideation.

Groups also raise issues of confidentiality. Participants share personal and family information that may involve third parties; confidentiality rules should be explained while acknowledging that the therapist cannot guarantee the behavior of other members outside the group. Digital autobiographical materials also require attention to data protection.

Research shows heterogeneity in intervention names, duration, comparators and the cognitive and clinical characteristics of participants. Outcomes are often symptom scales and life satisfaction rather than diagnoses of remission from major depression. This variability limits extrapolation of results and makes it inappropriate to speak of a single “effect of reminiscence therapy”.

Prognosis depends on the nature of the depressive disorder, comorbidities, social support, cognitive function and continuity of care. A favorable response to life review may improve symptoms and the sense of autobiographical coherence, but it does not eliminate relapse risk. Patients with recurrent depression should maintain a prevention plan based on their overall clinical profile.

The strongest overall conclusion is therefore that reminiscence based interventions, especially the more structured and therapeutic forms, can reduce depressive symptoms in many older adults. Their proper role is as a set of tools with a growing evidence base, to be selected and integrated according to the protocol, diagnosis and the patient's cognitive and clinical characteristics.

A further methodological limitation concerns the difficulty of constructing control conditions that are perfectly equivalent in time, attention and social contact. If the comparison group receives little interaction, part of the observed benefit may reflect common factors rather than autobiographical recall itself. Trials with active controls and well described protocols are therefore particularly important for estimating the specific contribution of life review.

Bibliography
1. Lin CL et al. Comparative effectiveness of reminiscence-based therapies on depressive symptoms and life satisfaction in older adults: a network meta-analysis of randomised controlled trials. Age and Ageing. 55(3), 2026, afag075.
2. Lin J et al. Looking back on life: An updated meta-analysis of the effect of life review therapy and reminiscence on late-life depression. Journal of Affective Disorders. 347, 2024, 163-174.
3. Pinquart M. Effects of reminiscence interventions on depression and anxiety: a meta-analysis of randomized controlled trials. Aging & Mental Health. 28(5), 2024, 717-724.
4. Pinquart M et al. Effects of reminiscence interventions on psychosocial outcomes: a meta-analysis. Aging & Mental Health. 16(5), 2012, 541-558.
5. Korte J et al. Life review therapy for older adults with moderate depressive symptomatology: a pragmatic randomized controlled trial. Psychological Medicine. 42(6), 2012, 1163-1173.
6. Bohlmeijer E et al. Effects of reminiscence and life review on late-life depression: a meta-analysis. International Journal of Geriatric Psychiatry. 18(12), 2003, 1088-1094.
7. Butler RN. The life review: an interpretation of reminiscence in the aged. Psychiatry. 26(1), 1963, 65-76.
8. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. 2022; last reviewed 2026.
9. Lam RW et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry. 69(9), 2024, 641-687.
10. Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Version 4.0. Washington, DC, 2022.
11. American Psychological Association. Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts. Washington, DC: American Psychological Association, 2019.
12. Cuijpers P et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 20(2), 2021, 283-293.
13. Cuijpers P et al. Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: a comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry. 22(1), 2023, 105-115.
14. Cuijpers P et al. Psychologic Treatment of Depression Compared With Pharmacotherapy and Combined Treatment in Primary Care: A Network Meta-Analysis. Annals of Family Medicine. 19(3), 2021, 262-270.